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ABSTRACT
With a worldwide prevalence of 5%, attention
deficit hyperactivity disorder (ADHD) has become
one of the most common psychiatric disorders.
The polygenetic nature of ADHD indicates that
multiple genes jointly contribute to the development
of this complex disease. Studies aiming to explore
genetic susceptibility of ADHD have been increasing
in recent years. There is a growing need to integrate
the genetic data from various genetic studies to
provide a comprehensive data set and uniform
access for convenience of in-depth data mining.
So far, there has been no such effort for ADHD. To
address the genetic complexity of ADHD, we de-
veloped the ADHDgene database by integrating
ADHD-related genetic factors by profound literature
reading. Based on the data from the literature,
extended functional analysis, including linkage dis-
equilibrium analysis, pathway-based analysis and
gene mapping were performed to provide new
insights into genetic causes of ADHD. Moreover,
powerful search tools and a graphical browser
were developed to facilitate the navigation of the
data and data connections. As the first genetic
database for ADHD, ADHDgene aims to provide re-
searchers with a central genetic resource and
analysis platform for ADHD and is freely available
at http://adhd.psych.ac.cn/.
INTRODUCTION
Attention deﬁcit hyperactivity disorder (ADHD) is one
of the most common psychiatric disorders with a world-
wide prevalence of 5% (1). The prevalence is even higher
among school-age children ranging from 8% to 12% (2,3).
ADHD is predominantly childhood-onset and can persist
into adolescence and adulthood to inﬂict long-term harm.
It is characterized by a continuous and combined pattern
of inattentive, hyperactive and impulsive behavior, and is
often comorbid with other psychiatric disorders (4).
Patients with ADHD have impaired academic, executive
and social functions, which also lead to a serious ﬁnancial
burden to families and society. Although the etiology of
ADHD is still incompletely understood, results from
family, twin and adoption studies, as well as molecular
genetic studies consistently indicate the strong genetic in-
ﬂuence on ADHD with estimated heritability ranging
from 75% to 91% (5). To date, the polygenetic nature
of ADHD is widely acknowledged, which indicates
multiple genes of moderate effect are involved in the
genetic basis of ADHD (6). Meanwhile, alternative
modes of inheritance in ADHD remain a topic for
further clariﬁcation. For example, evidences from the seg-
regation analysis demonstrated that a few major genes
convey susceptibility to ADHD and they exhibit
Mendelian segregation (7). Thus, to study the genetic
basis of ADHD is of fundamental importance in uncover-
ing disease mechanism and in developing effective
methods for ADHD diagnosis, treatment and prevention.
During the past years, numerous studies aiming to
explore genetic susceptibility of ADHD have been pub-
lished. Large numbers of association studies (8), linkage
studies (9) and meta-analyses (10) have been conducted,
and numbers of susceptibility variants, genes and chromo-
somal regions have been reported to be associated with
ADHD. For example, both genome-wide linkage and
ﬁne mapping studies support the linkage between
ADHD and chromosome bands 16p13 (11,12). Genes of
the dopaminergic and serotonergic system, including
DRD4, SLC6A3 (DAT1) and DBH, were widely studied
and implicated to be associated with the susceptibility of
ADHD. Several genome-wide association studies
(GWAS) have been conducted (13), and studies of
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have also emerged in recent years and identiﬁed some rare
or large deletions/duplications in ADHD patients (14–16).
However, these results are scattered in numerous publica-
tions and sometimes are equivocal or inconsistent. For
example, a candidate–gene association study using a
sample of 674 families indicated that both genes, DRD4
and SLC6A3, are associated with ADHD respectively
(17), while results from a case–control study did not ﬁnd
any association between these two genes and ADHD (18).
As these inconsistent results are common in genetic
studies, it would be difﬁcult for researchers to acquire a
global understanding of these positive and negative
ﬁndings, and then design the right kind of study to
move forward. The difﬁculty will be signiﬁcantly increased
with the fast growth of genetic data. Thus, to address the
genetic complexity of ADHD and the heterogeneity of
studies, a comprehensive and well-organized collection
of genetic data from multiple published studies is
urgently needed. Moreover, an association study, as the
currently most favored and widely used approach for
genetic study, usually identiﬁes trait-associated genetic
markers rather than causal variants affecting the trait.
Regular data analysis of an association study examines
SNPs/genes independently and ignores the combined
SNP/gene effects. In order to take the best advantage of
the current genetic data, in-depth data mining is urgently
needed to provide new candidates and new insights into
the mechanism of ADHD.
Here, we present ADHDgene, a genetic database for
ADHD, to fulﬁll the growing needs of data integration
and data analysis. Currently, there are several genetic
databases focusing on psychiatric disorders, like the
database of genetic studies of bipolar disorder (19),
SzGene (20) and SZGR (21) for schizophrenia, and
AutDB (22) and AGD (23) for autism. However, there
has been no such effort for ADHD. As the ﬁrst genetic
database for ADHD, ADHDgene aims to provide the
research community with a comprehensive set of genetic
data from both profound literature screening and
extended functional analysis. ADHDgene also provides
online tools to search and browse different data types
and data connections. In general, ADHDgene is
designed to be a central genetic database for ADHD to
facilitate the study of function and mechanism to help
unveil the genetic basis of ADHD.
DATA CONTENT, DATA INTEGRATION AND
ANALYSIS
Data content
The key data types in ADHDgene include variants (SNP,
CNV, etc.), genes and chromosomal regions. There are
mainly two sets of data hosted by ADHDgene. One is
the core data, which was derived from full-text literature
reading with manual curation of ADHD genetic studies
from the PubMed database at NCBI (http://www.ncbi
.nih.gov/pubmed). The other is the extended data derived
from extended functional analysis based on the core data,
including linkage disequilibrium (LD) analysis of the
literature-origin SNPs, pathway-based analysis (PBA)
for the GWAS of ADHD and gene mapping. A full an-
notation was made for both data sets, including SNP func-
tional annotation (such as non-synonymous coding SNPs,
or SNPs leading to gain or lost of stop codon) and GO
and KEGG pathway annotation for genes. Public data-
bases utilized for the mapping and annotation include
dbSNP (24), Ensembl (25), HGNC (26), UCSC (27), GO
(28) and KEGG (29). The data statistics of ADHDgene
dated 1 August 2011 is shown in Table 1. All data can be
freely downloaded from our website.
Core data: integration and curation
The core data of ADHDgene integrates ADHD-related
genetic factors from published literature. Besides SNP
and CNV, other variants like variable number tandem
repeat (VNTR) and microsatellite are also included. To
obtain the core data, a comprehensive search of ADHD
related genetic publications in PubMed was made by using
the following search term: (‘attention deﬁcit hyperactivity
disorder’ [Title/Abstract] OR ADHD [Title/Abstract])
AND (gene [Title/Abstract] OR genetic [Title/Abstract]
OR genome [Title/Abstract] OR genomic [Title/
Abstract]) AND (linkage [Title/Abstract] OR association
[Title/Abstract] OR polymorphism [Title/Abstract] OR
SNP [Title/Abstract] OR variant [Title/Abstract] OR vari-
ation [Title/Abstract] OR mutation [Title/Abstract]). It
resulted in 780 English publications from the year 2000
through 30 June 2011. By manual screening of abstracts of
these publications, only publications about association
studies, linkage studies and meta-analyses were kept for
further reading. Other publications like reviews or articles
about pharmacology, sociology, electrophysiology, neuro-
physiology and behavioral research were excluded. After
ﬁltering, there are 288 articles included in ADHDgene.
The full text of each eligible publication was read careful-
ly, and detailed information of each study was extracted
manually. To ensure a comprehensive review, both
positive and negative results were collected.
To illustrate the association between genetic candidates
and ADHD, statistical results were further evaluated and
were categorized into ‘Signiﬁcant’, ‘Non-signiﬁcant’ and
‘Trend’ according to their statistical evidence in the
original publications. For linkage study, the signiﬁcance
levels were assigned based on the criteria proposed by
Lander and Kruglyak (30). For candidate–gene associ-
ation studies, a signiﬁcance level of P<0.05 was used
unless the authors suggested some other value. The
result of statistical analysis is deﬁned as ‘Signiﬁcant’ if
the corresponding P-value is <0.05. For GWAS,
P<110
8 indicates a ‘Signiﬁcant’ result, P>110
5
indicates a ‘Non-signiﬁcant’ result, and a value between
these boundaries represents a ‘Trend’ result. Mutations
identiﬁed in ADHD patients were all classiﬁed as
‘Trend’ unless statistical signiﬁcance was proposed.
Meanwhile, to help understand the results from statistical
analysis, for each study, the study design, sample popula-
tion, analytical method, as well as brief comments from
authors, were presented to provide researchers a clear
picture for each genetic factor.
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The polygenetic nature of ADHD indicates that multiple
genes jointly contribute to the development of ADHD
with each having a modest effect on the overall risk (31).
Although current research has reported many candidate
SNPs and genes for ADHD, few are conclusive due to the
low replication rate, or lack of functional evidence on
mechanism through which the susceptibility genes jointly
affect the trait. With the purpose to identify more candi-
date SNPs and genes, as well as to allow a deeper inter-
pretation of current data, we performed extended
functional analysis based on the core data, which
includes LD analysis, pathway-based analysis and gene
mapping. These analyses enriched the content of the
database to provide new clues for understanding
the pathological mechanism of ADHD.
Linkage disequilibrium (LD) analysis. Association studies
have identiﬁed many SNPs as candidate genetic markers
for ADHD, but most of them lack function, e.g. some
intronic SNPs, ﬂanking SNPs or synonymous coding
SNPs. Linkage disequilibrium (LD) analysis searches the
LD-proxies of the literature-origin SNPs with the purpose
to capture more candidate SNPs, especially those candi-
date causal SNPs based on functional annotation. These
extended LD-proxies will provide new candidate SNPs for
future study designs.
The LD data used in this analysis were downloaded
from the HapMap website, which was compiled from
merged genotype data from phases I+II+III (HapMap
rel #27, NCBI B36) for markers up to 200kb apart (32).
SNPs in LD (r
2>0.8) with published SNPs were deﬁned
as LD-proxies. The population used in the LD analysis is
consistent with original studies. For example, the
LD-proxies of SNP rs2873804, which was identiﬁed in
the Chinese population, were extracted from HapMap
LD data in the CHB, CHD and JPT populations (32).
Pathway-based analysis (PBA) for genome-wide
association study (GWAS). So far, ﬁve genome-wide
association studies (GWASs) have been conducted for
ADHD but few signiﬁcant SNPs were found (33–37). As
the original GWAS analysis focuses on single SNP/gene,
combined SNP/gene effects are hardly explored, which
leads to difﬁculties in understanding the biological
function and mechanism of complex diseases (38). To
overcome this limitation, we implemented a pathway-
based analysis (PBA) algorithm, named i-GSEA
(improved gene set enrichment analysis) developed in
our recent studies (39,40), on the full list of GWAS SNP
P-values to detect pathways/gene sets associated with
ADHD. i-GSEA utilizes a re-scaled enrichment score
(ES) to emphasize pathways with well evaluated high pro-
portion of signiﬁcant genes to identify pathways/gene sets
with combined effects of modest genes involved in
complex disease. False discovery rate (FDR) is calculated
for each pathway/gene set and pathways/gene sets with
FDR<0.05 are regarded as statistical signiﬁcance.
The ADHD GWAS data sets (full list of SNP P-values)
were requested by emailing the corresponding authors of
related publications or through dbGaP (41). Finally, two
GWAS data sets were authorized. One is from a
family-based GWAS using SNP array (35), and the
other is from a case–control GWAS with pooled DNA
(34). i-GSEA was performed on the above two data sets
by using default parameters (39) with annotated GO terms
from MSigDB 3.0 (42) as reference database. In total, the
PBA analyses resulted in 8 pathways/gene sets signiﬁcant-
ly associated with ADHD (FDR<0.05). Among them,
the pathway annotated by GO term GO:0005262 repre-
sents a set of genes related to calcium channel activity,
which has been reported to infer the etiology of other
psychiatric disorders (43,44). This result provides new
evidence for possible shared biological mechanisms
between ADHD and other psychiatric disorders.
Gene mapping. To ensure a comprehensive collection of
candidate genes for ADHD, published SNPs, which
were not mapped to genes in the original publications,
and LD-proxies from LD analysis were mapped to genes
according to their chromosomal locations. Mapping
Table 1. ADHDgene data content and statistics as of 1 August 2011
Data set
a Data type Data statistics
b
Core data Variant SNP 941 (291)
CNV 296 (NA)
Others
c 160 (41)
Gene 213 (83)
Region 127 (29)
Extended data Variant LD-proxy 4120
Gene Mapped by published SNP 65
Mapped by LD-proxy 140
Mapped by CNV 891
Mapped by signiﬁcant region 2295
In pathway identiﬁed by PBA 260
Pathway Pathway identiﬁed by PBA 8
aThe core data is entirely from the literature, while the extended data is from extended functional analysis
bNumber in parenthesis indicates the number of statistically signiﬁcant results
cOther variants include VNTR, microsatellite, STR, duplication, SNP without reference SNP ID in dbSNP, etc. CNV, copy number variation; PBA,
pathway-based analysis; NA, not applicable.
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chromosomal regions were performed as well. All genes
acquired by the above mappings, as well as genes in
pathways identiﬁed by PBA, were regarded as the
extended candidate genes for ADHD. This part of genes
is distinguished as ‘genes from other sources’ in compari-
son to the ‘literature-origin genes’ from the core data in
ADHDgene database.
DATABASE USAGE AND ACCESS
ADHDgene provides researchers with a powerful search
engine and a user-friendly interface to access and browse
different data types and data connections. To search the
database efﬁciently, besides ‘Quick Search’ by keyword,
ADHDgene offers ‘Advanced Search’ for variant, gene,
region, pathway and publication to allow users to
specify and combine query options. Particularly, to facili-
tate a thorough investigation on the core data,
ADHDgene supports ‘Cross Search’ between different
genetic factors (variant, gene and region) and publication,
which helps to provide a thorough overview for each
genetic factor. For example, users may want to know
how many statistically signiﬁcant associations have been
reported for gene dopamine beta-hydroxylase (DBH)i n
the young generations of Caucasian populations.
Through ‘Cross Search’, users may input the gene name
‘DBH’, select ‘Signiﬁcant’ in the ﬁeld ‘Result of statistical
analysis’, input ‘Caucasian’ in the ﬁeld ‘Population’ and
select ‘Children/Adolescents’ in the ﬁeld ‘Age group’.
ADHDgene provides a detailed report for each genetic
factor. Taking the gene DBH for example, on its ‘Gene
Report’, DBH-related 16 publications and key results
from each publication are listed. Among them, nine
articles reported signiﬁcant associations with ADHD,
and seven reported non-signiﬁcant associations. To
assess the heterogeneity of these studies, users may link
to the ‘Publication Report’ to view the details. Other
genetic factors related to DBH are all listed, such as
SNPs (literature-origin or LD-proxies), CNVs, regions,
and genes sharing same pathway with DBH (by
database annotation or PBA, which indicate potential
candidates for epistasis study). It is worth mentioning
that there are 12 LD-proxies identiﬁed for DBH. Five of
them have been reported to have linkage or association
signals with other diseases, like schizophrenia (45,46) and
Parkinson’s disease (47). It is likely that these LD-proxies
could be possible candidate markers for ADHD.
Besides the search module, GBrowse (48) was
incorporated in ADHDgene to facilitate viewing the dif-
ferent types of genetic factors (variant/gene/region) simul-
taneously in the context of genomic regions. GBrowse is a
popular visualization tool for visualizing genetic and
genomic data. Entries from the literature and extended
functional analysis are marked in different colors in the
browser. Users can also link to the detail page of corres-
ponding entries from the browser. In summary, through
the above search and browse tools, users can access and
view the logical connections between different genetic
factors with strong evidence support either from the lit-
erature or from functional analysis (Figure 1).
SYSTEM DESIGN AND IMPLEMENTATION
All data of ADHDgene are stored and managed in a
MySQL relational database. The website is implemented
using JSP running on an Apache Tomcat web server.
Struts framework and Hibernate were employed to help
improve the stability of the web services. AJAX and some
jQuery plugins were used for the interface development.
The data analysis programs were written by PERL.
GBrowse uses MySQL as backend and was built following
the conﬁguration ﬁles provided by its developer (http://
gmod.org/wiki/GBrowse_Conﬁguration_HOWTO). The
genomic data in ADHDgene are loaded into GBrowse
after being converted into genome feature format (GFF).
DISCUSSION AND FUTURE DEVELOPMENT
As the ﬁrst genetic database for ADHD, ADHDgene was
developed to provide a panoramic view of present genetic
studies for this disease. ADHDgene covers a broad range
of data types including not only SNPs, genes, chromosom-
al regions and pathways, but also variants like CNV,
VNTR and microsatellites. By integrating data from
both publications and extended functional analysis,
ADHDgene provides a comprehensive genetic data set
for ADHD. In comparison to other disease-centered
genetic databases, ADHDgene was developed in a
reliable (manual curation of literature) but not limited
(extended functional analysis) way to fulﬁll the increasing
research demands in addressing the genetic complexity of
ADHD. By providing powerful search and browse tools,
the ADHDgene database aims to act as not only an
integrated genetic resource for ADHD, but also as a
ﬂexible application platform for the genetic study of
ADHD.
In the next few years, the number of genetic studies of
ADHD is expected to keep increasing especially with the
development of new technologies, such as next generation
sequencing (49). ADHDgene will be periodically updated
to ensure a most up-to-date follow up of the genetic
research progress of ADHD. It should be noted that
pathways by PBA in ADHDgene provide potential
hypotheses for further study rather than conclusive
results, since the results from PBA might be affected by
the quality of GWAS data (50). As soon as additional high
quality GWAS data become available, we will analyze
them to update the PBA results in ADHDgene.
Meanwhile, as studies of rare variants, epigenetics,
large-scale gene expression and gene–environment inter-
play for ADHD are expected to accelerate, the scope of
ADHDgene will be expanded to integrate newly generated
data. Evidence from animal models will also be one of the
future efforts in updating ADHDgene. We hope our con-
tinuous efforts will help to unveil the genetic basis of
ADHD and to contribute to global mental health.
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